# PubMed record PMID 17571443

> PeptideScanner retained PubMed bibliographic metadata for PMID 17571443 at 2026-07-30T16:30:45.652Z. PubMed recorded a metadata revision date of 2026-01-28 and an Entrez history date of 2007-06-19. PeptideScanner associated this retained record with the identity slug tesamorelin. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-17571443-tesamorelin:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-01-28
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-17571443-tesamorelin/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-17571443-tesamorelin-v1.json
- Content SHA-256: `ce419f545bc5ce87c655c849159b7b8f531bb69a05b397ca42e00fcc54efa0a4`

## Claims and source pins

### Headline

PubMed record PMID 17571443 ([`pubmed-observation-pmid-17571443-2026-01-28-c464a5a138fc`](#source-pubmed-observation-pmid-17571443-2026-01-28-c464a5a138fc))

### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 17571443 at 2026-07-30T16:30:45.652Z. PubMed recorded a metadata revision date of 2026-01-28 and an Entrez history date of 2007-06-19. PeptideScanner associated this retained record with the identity slug tesamorelin. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-17571443-2026-01-28-c464a5a138fc`](#source-pubmed-observation-pmid-17571443-2026-01-28-c464a5a138fc))

### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 17571443 at 2026-07-30T16:30:45.652Z. PubMed recorded a metadata revision date of 2026-01-28 and an Entrez history date of 2007-06-19. PeptideScanner associated this retained record with the identity slug tesamorelin. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-17571443-2026-01-28-c464a5a138fc`](#source-pubmed-observation-pmid-17571443-2026-01-28-c464a5a138fc))

### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-17571443-2026-01-28-c464a5a138fc`](#source-pubmed-observation-pmid-17571443-2026-01-28-c464a5a138fc))

## Sources

<a id="source-pubmed-observation-pmid-17571443-2026-01-28-c464a5a138fc"></a>
- **PubMed record PMID 17571443 · retained source version 1:2026-01-28:current:c464a5a138fc8cfd8edae6fcc473223b00cf2950436e88ae44f381eaa4f9dd26** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/17571443/) (`pubmed-observation-pmid-17571443-2026-01-28-c464a5a138fc`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "PubMed record PMID 17571443." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-17571443-tesamorelin-v1.json SHA-256: ce419f545bc5ce87c655c849159b7b8f531bb69a05b397ca42e00fcc54efa0a4.

